The U.S. Food and Drug Administration is revising the labeling of all extended-release attention-deficit/hyperactivity ...

The U.S. Food and Drug Administration said on Monday it is revising the labeling of all extended-release stimulants used to ...

The U.S. Food and Drug Administration said on Monday it is revising the labeling of all extended-release stimulants to treat ...

When combined, a subjective list of common childhood behaviors (fidgeting, losing things, distractibility, not following ...

Labels of all extended-release stimulants indicated for ADHD -- including certain formulations of amphetamine and ...

Researchers reviewing nearly 300 top-tier ADHD drug trials found that half skipped the rigorous, expert-led evaluations ...

The FDA now requires updated labeling for all extended-release stimulant medications used to treat attention deficit hyperactivity disorder, warning of increased risk of weight loss and other side ...

Children younger than 6 years of age who are prescribed extended-release stimulants for attention-deficit hyperactivity disorder (ADHD) may experience ...

Telehealth prescribing of stimulants for teens and adults with ADHD is not linked to a higher risk for substance use disorder vs in-person prescribing, a new study shows.

Agency will require a Limitation of Use section in the prescribing information of all extended-release ADHD stimulants.

The Food and Drug Administration is revising the labeling of all extended-release stimulants used to treat attention-deficit ...

The U.S. Food and Drug Administration said on Monday it is revising the labeling of all extended-release stimulants used to treat attention-deficit hyperactivity disorder to include warnings about ...